BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19347305)

  • 1. Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy.
    Martin CM; Astbury K; McEvoy L; O'Toole S; Sheils O; O'Leary JJ
    Methods Mol Biol; 2009; 511():333-59. PubMed ID: 19347305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling of cervical neoplasia.
    Martin CM; Astbury K; O'Leary JJ
    Expert Rev Mol Diagn; 2006 Mar; 6(2):217-29. PubMed ID: 16512781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV and cervical cancer: updates on an established relationship.
    Subramanya D; Grivas PD
    Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene identification by cDNA arrays in HPV-positive cervical cancer.
    Vázquez-Ortíz G; Ciudad CJ; Piña P; Vazquez K; Hidalgo A; Alatorre B; Garcia JA; Salamanca F; Peralta-Rodriguez R; Rangel A; Salcedo M
    Arch Med Res; 2005; 36(5):448-58. PubMed ID: 16099320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
    Santin AD; Zhan F; Bignotti E; Siegel ER; Cané S; Bellone S; Palmieri M; Anfossi S; Thomas M; Burnett A; Kay HH; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Virology; 2005 Jan; 331(2):269-91. PubMed ID: 15629771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.
    Martin CM; Kehoe L; Spillane CO; O'Leary JJ
    Mol Diagn Ther; 2007; 11(5):277-90. PubMed ID: 17963416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of proteomics in translational research in cervical cancer.
    Yim EK; Park JS
    Expert Rev Proteomics; 2006 Feb; 3(1):21-36. PubMed ID: 16445348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross platform microarray analysis for robust identification of differentially expressed genes.
    Bosotti R; Locatelli G; Healy S; Scacheri E; Sartori L; Mercurio C; Calogero R; Isacchi A
    BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S5. PubMed ID: 17430572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new E6/P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells.
    Teissier S; Ben Khalifa Y; Mori M; Pautier P; Desaintes C; Thierry F
    J Virol; 2007 Sep; 81(17):9368-76. PubMed ID: 17582001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
    Yugawa T; Kiyono T
    Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for cervical cancer-related genes and their bioinformatics analysis].
    Chen SZ; Ma WL; Zheng WL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):585-8. PubMed ID: 18495597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(A) cDNA real-time PCR for indicator gene measurement in cancer.
    Oliveira-Cunha M; Siriwardena AK; Byers RJ
    Methods Mol Biol; 2010; 630():13-32. PubMed ID: 20300988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L; Commo F; Soria JC
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.
    Jeantet D; Schwarzmann F; Tromp J; Melchers WJ; van der Wurff AA; Oosterlaken T; Jacobs M; Troesch A
    J Clin Virol; 2009 Jul; 45 Suppl 1():S29-37. PubMed ID: 19651366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of biomarkers for cervical cancer in peripheral blood lymphocytes using oligonucleotide microarrays.
    Sheng J; Zhang WY
    Chin Med J (Engl); 2010 Apr; 123(8):1000-5. PubMed ID: 20497704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of human tumour antigens: Current status and future developments.
    Miles AK; Matharoo-Ball B; Li G; Ahmad M; Rees RC
    Cancer Immunol Immunother; 2006 Aug; 55(8):996-1003. PubMed ID: 16408215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes differentially expressed in prostate cancer.
    Eder IE; Bektic J; Haag P; Bartsch G; Klocker H
    BJU Int; 2004 May; 93(8):1151-5. PubMed ID: 15142130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblasts.
    Xi L; Wang S; Wang C; Xu Q; Li P; Tian X; Wu P; Wang W; Deng D; Zhou J; Ma D
    Oncol Rep; 2009 Jan; 21(1):25-31. PubMed ID: 19082439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications.
    Sugimura J; Yang XJ; Tretiakova MS; Takahashi M; Kort EJ; Fulton B; Fujioka T; Vogelzang NJ; Teh BT
    Urology; 2004 Aug; 64(2):362-8; discussion 368. PubMed ID: 15302496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targets in gynaecological cancers.
    Cheung AN
    Pathology; 2007 Feb; 39(1):26-45. PubMed ID: 17365821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.